ATBPF
Price
$0.22
Change
+$0.03 (+15.79%)
Updated
Apr 8 closing price
Capitalization
11.43M
SRZN
Price
$12.08
Change
+$0.23 (+1.94%)
Updated
Jan 17 closing price
Capitalization
39.26M
Ad is loading...

ATBPF vs SRZN

Header iconATBPF vs SRZN Comparison
Open Charts ATBPF vs SRZNBanner chart's image
Antibe Therapeutics
Price$0.22
Change+$0.03 (+15.79%)
Volume$33.94K
Capitalization11.43M
Surrozen
Price$12.08
Change+$0.23 (+1.94%)
Volume$32.33K
Capitalization39.26M
ATBPF vs SRZN Comparison Chart
Loading...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATBPF vs. SRZN commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATBPF is a Hold and SRZN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATBPF: $0.22 vs. SRZN: $12.08)
Brand notoriety: ATBPF and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATBPF: 100% vs. SRZN: 64%
Market capitalization -- ATBPF: $11.43M vs. SRZN: $39.26M
ATBPF [@Biotechnology] is valued at $11.43M. SRZN’s [@Biotechnology] market capitalization is $39.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATBPF’s FA Score shows that 0 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • ATBPF’s FA Score: 0 green, 5 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATBPF and SRZN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRZN’s TA Score shows that 6 TA indicator(s) are bullish.

  • SRZN’s TA Score: 6 bullish, 4 bearish.

Price Growth

ATBPF (@Biotechnology) experienced а 0.00% price change this week, while SRZN (@Biotechnology) price change was +8.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

SRZN is expected to report earnings on Mar 21, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRZN($39.3M) has a higher market cap than ATBPF($11.4M). ATBPF YTD gains are higher at: 0.000 vs. SRZN (-15.819).
ATBPFSRZNATBPF / SRZN
Capitalization11.4M39.3M29%
EBITDAN/A-25.06M-
Gain YTD0.000-15.819-
P/E RatioN/AN/A-
RevenueN/A10M-
Total CashN/A31M-
Total DebtN/A1.53M-
FUNDAMENTALS RATINGS
ATBPF: Fundamental Ratings
ATBPF
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATBPFSRZN
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 11 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 11 days ago
72%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
83%
Bearish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 11 days ago
78%
View a ticker or compare two or three
Ad is loading...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UOPSX81.622.61
+3.30%
ProFunds UltraNASDAQ-100 Svc
RAFFX44.830.38
+0.85%
American Funds AMCAP R5
BGLCX13.360.05
+0.38%
Brookfield Global Listed InfrastructureC
SNOAX33.560.02
+0.06%
Easterly Snow Long/Short Opportunity A
GSDPX47.72N/A
N/A
Goldman Sachs US Tax-Managed Eq P

ATBPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATBPF has been loosely correlated with IRON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATBPF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATBPF
1D Price
Change %
ATBPF100%
N/A
IRON - ATBPF
53%
Loosely correlated
-2.84%
KMSTF - ATBPF
52%
Loosely correlated
N/A
SRZN - ATBPF
47%
Loosely correlated
+1.94%
CDIO - ATBPF
25%
Poorly correlated
-6.92%
ZVRA - ATBPF
22%
Poorly correlated
+1.51%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with ATBPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then ATBPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+1.94%
ATBPF - SRZN
46%
Loosely correlated
N/A
ALRN - SRZN
44%
Loosely correlated
N/A
IRON - SRZN
31%
Poorly correlated
-2.84%
ABCZF - SRZN
28%
Poorly correlated
N/A
KMSTF - SRZN
27%
Poorly correlated
N/A
More